INTERNATIONAL PATENT: AURIGENE ONCOLOGY LIMITED FILES APPLICATION FOR "FUSED BICYCLIC HETEROCYCLYL COMPOUNDS AND THEIR DERIVATIVES AS P300 SELECTIVE DEGRADERS"

GENEVA, March 17 -- AURIGENE ONCOLOGY LIMITED (39/40(P), KIADBIndustrial Area, ElectronicsCity Phase II, BangaloreKarnataka -560 100) filed a patent application (PCT/IB2025/058852) for "FUSED BICYCLIC HETEROCYCLYL COMPOUNDS AND THEIR DERIVATIVES AS P300 SELECTIVE DEGRADERS" on Sep 03, 2025. With publication no. WO/2026/053114, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ABBINENI, Chandrasekhar (Plot #387, IKIGAI, Journalists'colony phase 3, GopanpallyTelanganaHyderabad 500032), TALLURI, Krishna Chaitanya (Flat no. 401...